Carver Biosciences
carver.bioLocations
Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology
Size
1 - 10 employees
Stage
Seed
founded in
2022
Carver Biosciences is a startup company developing CRISPR-based therapies for RNA viruses that infect humans. Their programmable platform technology offers a generalizable solution for treating various viruses, with a focus on respiratory viruses like influenza A and COVID-19. Founded by Cameron Myhrvold, the company leverages two decades of experience in oligonucleotide therapeutics to target and degrade viral RNA, addressing a significant need for broad-spectrum antiviral therapies.
Something looks off?Open jobs at Carver Biosciences
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.